Innate Pharma SA (FR:IPH) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Innate Pharma SA has unveiled its 2025 financial calendar, with key dates for the release of its financial statements and shareholders meeting. Investors can expect updates on March 27, May 13, September 17, and November 13, as the company continues to advance its innovative cancer immunotherapies. Innate Pharma, listed on Euronext Paris and Nasdaq, partners with major biopharmaceutical firms like Sanofi and AstraZeneca.
For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.